{"cursor":"20576","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed verifiedrevid = 458438457 image = Rituximab.png\n| width = 300\n\n\n| type = mab mab_type = mab source = xi/o target = CD20\n\n| tradename = Rituxan Drugs.com = pregnancy_US = C pregnancy_category = (no\n| adequate human studies) legal_US = Rx-only legal_status =\n| routes_of_administration = intravenous infusion only (never bolus or \"push\")\n\n\n| bioavailability = 100% (IV) protein_bound = metabolism = elimination_half-life\n| = 30 to 400 hours (varies by dose and length of treatment) excretion =\n| Uncertain: may undergo phagocytosis and catabolism in RES\n\n\n| ChemSpiderID_Ref = ChemSpiderID = NA CAS_number_Ref = CAS_number = 174722-31-7\n| ATC_prefix = L01 ATC_suffix = XC02 ATC_supplemental = PubChem = DrugBank_Ref =\n| DrugBank = DB00073 UNII_Ref = UNII = 4F4X42SYQ6 KEGG_Ref = KEGG = D02994\n| ChEMBL_Ref = ChEMBL = 1201576\n\n\n| C=6416 | H=9874 | N=1688 | O=1987 | S=44 molecular_weight = 143859.7 g/mol\n}} 'Rituximab' (trade names 'Rituxan' and 'MabThera') is a chimeric monoclonal\nantibody against the protein CD20, which is primarily found on the surface of\nimmune system B cells (this should not be confused with pancreatic Î²- or beta\ncells). Rituximab destroys B cells, and is therefore used to treat diseases\nwhich are characterized by excessive numbers of B cells, overactive B cells, or\ndysfunctional B cells. This includes many lymphomas, leukemias, transplant\nrejection, and autoimmune disorders.\n","linknr":647,"url":"Rituximab","recorded":1374859177,"links":["/w/index.php?title=Rituximab&action=edit","/w/index.php?title=Rituximab&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/File:Rituximab.png","//upload.wikimedia.org/wikipedia/commons/thumb/d/d0/Rituximab.png/300px-Rituximab.png","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Monoclonal_antibody#Production","/wiki/Chimeric_antibody","/wiki/Mouse","/wiki/Human","/wiki/Antigen","/wiki/CD20","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/rituximab.html","/wiki/Pregnancy_category","/wiki/United_States","/wiki/Regulation_of_therapeutic_goods","/wiki/Prescription_drug","/wiki/United_States","/wiki/Route_of_administration","/wiki/Bioavailability","/wiki/Biological_half-life","/wiki/Excretion","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=174722-31-7&rn=1","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L01","http://www.whocc.no/atc_ddd_index/?code=L01XC02","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00073","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4F4X42SYQ6","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D02994","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201576","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=458438457&page2=Rituximab","/wiki/Chimera_(protein)","/wiki/Monoclonal_antibody","/wiki/CD20","/wiki/B_cells","/wiki/Beta_cell","/wiki/Lymphoma","/wiki/Leukemia","/wiki/Transplant_rejection","/wiki/Autoimmune_disorder","#History","#Uses","#Hematological_cancers","#Autoimmune_diseases","#Anti-rejection_treatment_for_organ_transplants","#Mechanism","#Adverse_events","#Other_anti-CD20_monoclonals","#References","#External_links","/w/index.php?title=Rituximab&action=edit&section=1","/wiki/Biogen_Idec","#cite_note-1","/wiki/Clinical_trial","#cite_note-2","/wiki/U.S._Food_and_Drug_Administration","/wiki/Non-Hodgkin_lymphoma","/wiki/Chemotherapy","#cite_note-3","/wiki/CHOP","/wiki/Diffuse_large_B-cell_lymphoma","#cite_note-4","/wiki/European_Commission","/wiki/Follicular_lymphoma","#cite_note-5","/wiki/Biogen_Idec","/wiki/Genentech","/wiki/Hoffmann%E2%80%93La_Roche","/wiki/European_Union","/wiki/Chugai_Pharmaceuticals","/w/index.php?title=Rituximab&action=edit&section=2","/wiki/B_cells","/w/index.php?title=Rituximab&action=edit&section=3","/wiki/Hematological_malignancy","/wiki/Leukemia","/wiki/Lymphoma","#cite_note-6","/wiki/Multiple_myeloma","#cite_note-7","/w/index.php?title=Rituximab&action=edit&section=4","/wiki/Rheumatoid_arthritis","#cite_note-8","/wiki/Methotrexate","/wiki/TNF-alpha","#cite_note-9","/wiki/Pharmacovigilance","/wiki/Off-label","/wiki/Multiple_sclerosis","#cite_note-10","/wiki/Systemic_lupus_erythematosus","/wiki/Anemia","#cite_note-NWU-11","/wiki/Progressive_multifocal_leukoencephalopathy","#cite_note-12","#cite_note-NWU-11","/wiki/Autoimmune_hemolytic_anemia","/wiki/Pure_red_cell_aplasia","/wiki/Idiopathic_thrombocytopenic_purpura","#cite_note-13","#cite_note-14","/wiki/Evans_syndrome","#cite_note-15","/wiki/Wegener%27s_Granulomatosis","/wiki/Pemphigus","/wiki/Pemphigoid","/wiki/Pemphigus","#cite_note-16","/wiki/Diabetes_mellitus","/wiki/Sjogren%27s_syndrome","/wiki/Devic%27s_disease","#cite_note-17","#cite_note-18","/wiki/Chronic_fatigue_syndrome","#cite_note-pmid19566965-19","#cite_note-20","#cite_note-21","#cite_note-22","/w/index.php?title=Rituximab&action=edit&section=5","/wiki/Kidney_transplant","/wiki/Wikipedia:Citation_needed","/w/index.php?title=Rituximab&action=edit&section=6","/wiki/File:Rituxan_in_action.jpg","//upload.wikimedia.org/wikipedia/commons/thumb/5/55/Rituxan_in_action.jpg/220px-Rituxan_in_action.jpg","/wiki/File:Rituxan_in_action.jpg","//bits.wikimedia.org/static-1.22wmf10/skins/common/images/magnify-clip.png","/wiki/Cluster_of_differentiation","/wiki/CD20","/wiki/Plasma_cell","/wiki/Calcium","#cite_note-23","#cite_note-24","#cite_note-25","/wiki/Fragment_crystallizable_region","/wiki/Antibody-dependent_cellular_cytotoxicity","/wiki/Complement_system","/wiki/Cell_cycle","/wiki/MHC_II","/wiki/CD23","/wiki/B_cell_receptor","/wiki/Apoptosis","/wiki/Stem_cell","/wiki/Amino_acid","/wiki/Disulfide_bond","#cite_note-26","/w/index.php?title=Rituximab&action=edit&section=7","/wiki/Death","/wiki/Disability","#cite_note-titleGenentech:_Products_-_Product_Information_-_Immunology_-_Rituxan_RA_Full_Prescribing_Information-27","/w/index.php?title=Infusion_reaction&action=edit&redlink=1","/wiki/Cardiac_arrest","/wiki/Cytokine_release_syndrome","/wiki/Tumor_lysis_syndrome","/wiki/Acute_renal_failure","/wiki/Hepatitis_B","/wiki/Progressive_multifocal_leukoencephalopathy","/wiki/Lymphoma","/wiki/Human_lung","#cite_note-28","/wiki/Systemic_lupus_erythematosus","/wiki/Progressive_multifocal_leukoencephalopathy","/wiki/JC_virus","#cite_note-urlRituximab_.28marketed_as_Rituxan.29_Information-29","/wiki/Rheumatoid_arthritis","#cite_note-urlRituximab.2C_RA_and_PML-30","/wiki/Hepatitis_E","/wiki/Acute_(medicine)","#cite_note-urlChronic_Hepatitis_After_Hepatitis_E_Virus_Infection_in_a_Patient_With_Non-Hodgkin_Lymphoma_Taking_Rituximab-31","/w/index.php?title=Rituximab&action=edit&section=8","/wiki/Ocrelizumab","/wiki/Ofatumumab","#cite_note-titleGenmab.com_.2F_HuMax-CD20_.28ofatumumab.29-32","#cite_note-titleFc-structure-33","/wiki/Antibody-dependent_cellular_cytotoxicity","#cite_note-titleMonoclonal_antibodies_targeting_cancer:_.27magic_bullets.27_or_just_the_trigger.3F-34","/w/index.php?title=Antibody_variable_region&action=edit&redlink=1","#cite_note-titlemonoclonal_domains-35","/wiki/Wikipedia:Citation_needed","/wiki/Belimumab","/wiki/Atacicept","/w/index.php?title=Rituximab&action=edit&section=9","#cite_ref-1","http://www.sandiegometro.com/1999/apr/biotech.html","#cite_ref-2","http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=9310469","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9310469","#cite_ref-3","http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1065-4704&date=1998&volume=6&issue=3&spage=195","/wiki/Digital_object_identifier","http://dx.doi.org/10.1046%2Fj.1523-5394.1998.006003195.x","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9652253","#cite_ref-4","#cite_ref-5","http://www.genengnews.com/gen-news-highlights/roche-gets-ec-nod-for-follicular-lymphoma-maintenance-therapy/81244149/","#cite_ref-6","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.ctrv.2010.11.005","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21183282","#cite_ref-7","http://www.doaj.org/doaj?func=abstract&id=260717&recNo=32&toc=1/","#cite_ref-8","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa032534","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15201414","#cite_ref-9","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123966","/wiki/Digital_object_identifier","http://dx.doi.org/10.1186%2F1478-6354-13-S1-S5","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3123966","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21624184","#cite_ref-10","http://content.nejm.org/cgi/content/short/358/7/676","#cite_ref-NWU_11-0","#cite_ref-NWU_11-1","http://www.northwestern.edu/newscenter/stories/2009/05/bennett.html","#cite_ref-12","http://www.fda.gov/bbs/topics/NEWS/2006/NEW01532.html","#cite_ref-13","/wiki/Digital_object_identifier","http://dx.doi.org/10.1002%2Fajh.20276","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/15795920","#cite_ref-14","http://www.communityoncology.net/journal/articles/0402107.pdf","#cite_ref-15","http://www.mayoclinicproceedings.com/pdf/7811/7811a3.pdf","#cite_ref-16","#cite_ref-17","http://archneur.ama-assn.org/cgi/content/full/65/11/1443","/wiki/Digital_object_identifier","http://dx.doi.org/10.1001%2Farchneur.65.11.noc80069","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18779415","#cite_ref-18","http://www.ophthalmologyjournaloftheaao.com/article/S0161-6420%2809%2900548-X/abstract","#cite_ref-pmid19566965_19-0","http://www.biomedcentral.com/1471-2377/9/28","/wiki/Digital_object_identifier","http://dx.doi.org/10.1186%2F1471-2377-9-28","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2711959","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/19566965","#cite_ref-20","http://clinicaltrials.gov/ct2/show/NCT00848692?term=chronic+fatigue+syndrome&rank=4","#cite_ref-21","http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026358","#cite_ref-22","http://www.research1st.com/2011/10/19/rituximab-trial/","#cite_ref-23","http://www.kurzweilai.net/scientists-discover-why-a-specific-cancer-drug-is-so-effective","/wiki/Digital_object_identifier","http://dx.doi.org/10.1182%2Fblood-2013-02-482570","#cite_ref-24","/wiki/Digital_object_identifier","http://dx.doi.org/10.1182%2Fblood-2013-02-482570","//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1182.2Fblood-2013-02-482570&action=edit&editintro=Template:Cite_doi/editintro2","#cite_ref-25","http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1766758","#cite_ref-26","/wiki/Digital_object_identifier","http://dx.doi.org/10.1182%2Fblood-2006-04-014639","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16705086","#cite_ref-titleGenentech:_Products_-_Product_Information_-_Immunology_-_Rituxan_RA_Full_Prescribing_Information_27-0","http://www.gene.com/gene/products/information/immunological/rituxan/insert.jsp","#cite_ref-28","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJM200306263482619","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12826649","#cite_ref-urlRituximab_.28marketed_as_Rituxan.29_Information_29-0","http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109106.htm","#cite_ref-urlRituximab.2C_RA_and_PML_30-0","http://www.fda.gov/medwatch/safety/2008/rituxan_DHCP_Final%209411700.pdf","#cite_ref-urlChronic_Hepatitis_After_Hepatitis_E_Virus_Infection_in_a_Patient_With_Non-Hodgkin_Lymphoma_Taking_Rituximab_31-0","http://www.annals.org/cgi/reprint/150/6/430-a.pdf","#cite_ref-titleGenmab.com_.2F_HuMax-CD20_.28ofatumumab.29_32-0","http://web.archive.org/web/20070911144653/http://www.genmab.com/ScienceAndResearch/ProductsinDevelopment/HuMax-CD20.aspx","http://www.genmab.com/ScienceAndResearch/ProductsinDevelopment/HuMax-CD20.aspx","#cite_ref-titleFc-structure_33-0","http://www.healthvalue.net/Fc-structure.html","#cite_ref-titleMonoclonal_antibodies_targeting_cancer:_.27magic_bullets.27_or_just_the_trigger.3F_34-0","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC138676","/wiki/Digital_object_identifier","http://dx.doi.org/10.1186%2Fbcr276","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC138676","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11250751","#cite_ref-titlemonoclonal_domains_35-0","http://www.healthvalue.net/monoclonaldomainsengl.html","/w/index.php?title=Rituximab&action=edit&section=10","http://www.mabthera.com","http://www.mabthera-ra.com","http://www.rituxan.com","http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109106.htm","/wiki/Food_and_Drug_Administration","http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Rituximab","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template_talk:Extracellular_chemotherapeutic_agents","//en.wikipedia.org/w/index.php?title=Template:Extracellular_chemotherapeutic_agents&action=edit","/wiki/Targeted_therapy","/wiki/Chemotherapy_(oncology)","/wiki/Antineoplastic","/wiki/ATC_code_L01","/wiki/Cancer_immunotherapy","/wiki/Monoclonal_antibody_therapy","/wiki/Receptor_tyrosine_kinase","/wiki/ErbB","/wiki/Epidermal_growth_factor_receptor","/wiki/Cetuximab","/wiki/Panitumumab","/wiki/HER2/neu","/wiki/Trastuzumab","/wiki/Trastuzumab_emtansine","/wiki/EpCAM","/wiki/Catumaxomab","/wiki/Edrecolomab","/wiki/Vascular_endothelial_growth_factor_A","/wiki/Bevacizumab","/wiki/Leukemia","/wiki/Lymphoma","/wiki/Lymphatic_system","/wiki/CD20","/wiki/Ibritumomab_tiuxetan","/wiki/Ofatumumab","/wiki/Tositumomab","/wiki/CD30","/wiki/Brentuximab_vedotin","/wiki/CD52","/wiki/Alemtuzumab","/wiki/Myeloid","/wiki/CD33","/wiki/Gemtuzumab_ozogamicin","/wiki/Tyrosine-kinase_inhibitor","/wiki/Receptor_tyrosine_kinase","/wiki/ErbB","/wiki/Epidermal_growth_factor_receptor","/wiki/Erlotinib","/wiki/Gefitinib","/wiki/Vandetanib","/wiki/HER2/neu","/wiki/Afatinib","/wiki/Lapatinib","/wiki/Neratinib","/wiki/RTK_class_III","/wiki/CD117","/wiki/Platelet-derived_growth_factor_receptor","/wiki/Axitinib","/wiki/Masitinib","/wiki/Pazopanib","/wiki/Sunitinib","/wiki/Sorafenib","/wiki/Toceranib","/wiki/CD135","/wiki/Lestaurtinib","/wiki/VEGF_receptors","/wiki/Axitinib","/wiki/Cediranib","/wiki/Pazopanib","/wiki/Regorafenib","/wiki/Semaxanib","/wiki/Sorafenib","/wiki/Sunitinib","/wiki/Toceranib","/wiki/Vandetanib","/wiki/Non-receptor_tyrosine_kinase","/wiki/Bcr-abl_fusion_protein","/wiki/Imatinib","/wiki/Dasatinib","/wiki/Nilotinib","/wiki/Ponatinib","/wiki/Src_(gene)","/wiki/Bosutinib","/wiki/Janus_kinase","/wiki/Lestaurtinib","/wiki/Ruxolitinib","/wiki/EML4","/wiki/Anaplastic_lymphoma_kinase","/wiki/Crizotinib","/wiki/Vandetanib","/wiki/Cabozantinib","/wiki/Fusion_protein","/wiki/Vascular_endothelial_growth_factor","/wiki/Aflibercept","/wiki/Proapoptotic","/wiki/ANXA2","/wiki/Prohibitin","/wiki/Adipotide","/wiki/Exotoxin","/wiki/Interleukin_2","/wiki/Denileukin_diftitox","/wiki/MTOR_inhibitor","/wiki/Everolimus","/wiki/Temsirolimus","/wiki/Template:Medicine_navs","/wiki/Neoplasm","/wiki/Template:Tumor_suppressor_genes_and_oncogenes","/wiki/Template:Tumor_markers","/wiki/Template:Tumors","/wiki/Template:Eponymous_medical_signs_for_oncology","/wiki/Template:Paraneoplastic_syndromes","/wiki/ATC_code_L","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment","/wiki/Template:Monoclonals_for_tumors","/wiki/Template_talk:Monoclonals_for_tumors","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_tumors&action=edit","/wiki/Monoclonal_antibodies","/wiki/Tumor","/wiki/Adecatumumab","/wiki/Cixutumumab","/wiki/Conatumumab","/wiki/Daratumumab","/wiki/Drozitumab","/wiki/Duligotumab","/wiki/Dusigitumab","/wiki/Figitumumab","/wiki/Ganitumab","/wiki/Glembatumumab_vedotin","/wiki/Intetumumab","/wiki/Iratumumab","/wiki/Lexatumumab","/wiki/Lucatumumab","/wiki/Mapatumumab","/wiki/Narnatumab","/wiki/Necitumumab","/wiki/Ofatumumab","/wiki/Olaratumab","/wiki/Panitumumab","/wiki/Patritumab","/wiki/Pritumumab","/wiki/Radretumab","/wiki/Rilotumumab","/wiki/Robatumumab","/wiki/Teprotumumab","/wiki/Tovetumab","/wiki/Vantictumab","/wiki/Technetium_(99mTc)_votumumab","/wiki/Zalutumumab","/wiki/Melanoma","/wiki/Flanvotumab","/wiki/Indium_(111In)_altumomab_pentetate","/wiki/Anatumomab_mafenatox","/wiki/Technetium_(99mTc)_arcitumomab","/wiki/Bectumomab","/wiki/Blinatumomab","/wiki/Iodine_(125I)_CC49","/wiki/Detumomab","/wiki/Ibritumomab_tiuxetan","/wiki/Minretumomab","/wiki/Mitumomab","/wiki/Moxetumomab_pasudotox","/wiki/Naptumomab_estafenatox","/wiki/Technetium_(99mTc)_nofetumomab_merpentan","/wiki/Pemtumomab","/wiki/Technetium_(99mTc)_pintumomab","/wiki/Racotumomab","/wiki/Indium_(111In)_satumomab_pendetide","/wiki/Solitomab","/wiki/Taplitumomab_paptox","/wiki/Tenatumomab","/wiki/Tositumomab","/wiki/3F8","/wiki/Ovarian_tumor","/wiki/Abagovomab","/wiki/Indium_(111In)_igovomab","/wiki/Oregovomab","/wiki/Indium_(111In)_capromab_pendetide","/wiki/Edrecolomab","/wiki/Nacolomab_tafenatox","/wiki/Chimeric_antibody","/wiki/Amatuximab","/wiki/Bavituximab","/wiki/Brentuximab_vedotin","/wiki/Cetuximab","/wiki/Ensituximab","/wiki/Futuximab","/wiki/Girentuximab","/wiki/Indatuximab_ravtansine","/wiki/Margetuximab","/wiki/Siltuximab","/wiki/Ublituximab","/wiki/Melanoma","/wiki/Ecromeximab","/wiki/Humanized_antibody","/wiki/Afutuzumab","/wiki/Alemtuzumab","/wiki/Bevacizumab","/wiki/Bivatuzumab_mertansine","/wiki/Cantuzumab_mertansine","/wiki/Cantuzumab_ravtansine","/wiki/Citatuzumab_bogatox","/wiki/Yttrium_(90Y)_clivatuzumab_tetraxetan","/wiki/Dacetuzumab","/wiki/Dalotuzumab","/wiki/Elotuzumab","/wiki/Etaracizumab","/wiki/Farletuzumab","/wiki/Ficlatuzumab","/wiki/Gemtuzumab_ozogamicin","/wiki/Imgatuzumab","/wiki/Inotuzumab_ozogamicin","/wiki/Labetuzumab","/wiki/Lintuzumab","/wiki/Lorvotuzumab_mertansine","/wiki/Matuzumab","/wiki/Milatuzumab","/wiki/Nimotuzumab","/wiki/Ocaratuzumab","/wiki/Onartuzumab","/wiki/Oportuzumab_monatox","/wiki/Parsatuzumab","/wiki/Pertuzumab","/wiki/Sibrotuzumab","/wiki/Simtuzumab","/wiki/Yttrium_(90Y)_tacatuzumab_tetraxetan","/wiki/Tigatuzumab","/wiki/Trastuzumab","/wiki/Tucotuzumab_celmoleukin","/wiki/Veltuzumab","/wiki/Vorsetuzumab_mafodotin","/wiki/Trifunctional_antibody","/wiki/Catumaxomab","/wiki/Ertumaxomab","/wiki/Ontuxizumab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Rituximab&oldid=565153825","/wiki/Help:Categories","/wiki/Category:Monoclonal_antibodies_for_tumors","/wiki/Category:Orphan_drugs","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/wiki/Category:All_articles_with_unsourced_statements","/wiki/Category:Articles_with_unsourced_statements_from_February_2011","/wiki/Category:Articles_with_unsourced_statements_from_October_2010","/w/index.php?title=Special:UserLogin&returnto=Rituximab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Rituximab","/wiki/Rituximab","/wiki/Talk:Rituximab","#","/wiki/Rituximab","/w/index.php?title=Rituximab&action=edit","/w/index.php?title=Rituximab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf10/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Rituximab","/wiki/Special:RecentChangesLinked/Rituximab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Rituximab&oldid=565153825","/w/index.php?title=Rituximab&action=info","//www.wikidata.org/wiki/Q412323","/w/index.php?title=Special:Cite&page=Rituximab&id=565153825","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Rituximab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Rituximab&oldid=565153825&writer=rl","/w/index.php?title=Rituximab&printable=yes","//de.wikipedia.org/wiki/Rituximab","//es.wikipedia.org/wiki/Rituximab","//fr.wikipedia.org/wiki/Rituximab","//it.wikipedia.org/wiki/Rituximab","//hu.wikipedia.org/wiki/Rituximab","//nl.wikipedia.org/wiki/Rituximab","//ja.wikipedia.org/wiki/%E3%83%AA%E3%83%84%E3%82%AD%E3%82%B7%E3%83%9E%E3%83%96","//no.wikipedia.org/wiki/Rituximab","//pl.wikipedia.org/wiki/Rytuksymab","//pt.wikipedia.org/wiki/Rituximabe","//sl.wikipedia.org/wiki/Rituksimab","//fi.wikipedia.org/wiki/Rituksimabi","//sv.wikipedia.org/wiki/Rituximab","//zh.wikipedia.org/wiki/%E5%88%A9%E5%A6%A5%E6%98%94%E5%96%AE%E6%8A%97","#","//www.wikidata.org/wiki/Q412323#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Rituximab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf10/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["medicine","protein"],"pdf":["http://www.mayoclinicproceedings.com/pdf/7811/7811a3.pdf","http://www.fda.gov/medwatch/safety/2008/rituxan_DHCP_Final%209411700.pdf","http://www.annals.org/cgi/reprint/150/6/430-a.pdf"],"categories":["Monoclonal antibodies for tumors","Orphan drugs"],"headings":["History","Uses","Mechanism","Adverse events","Other anti-CD20 monoclonals","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/d/d0/Rituximab.png/300px-Rituximab.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/5/55/Rituxan_in_action.jpg/220px-Rituxan_in_action.jpg","//bits.wikimedia.org/static-1.22wmf10/skins/common/images/magnify-clip.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["chimera","protein"],["acute","medicine"]],"members":["acute","chimera"],"related":["CD20","Chimera_(protein)","Monoclonal_antibody","CD20","B_cells","Beta_cell","Lymphoma","Leukemia","Transplant_rejection","Autoimmune_disorder","Biogen_Idec","Clinical_trial","U.S._Food_and_Drug_Administration","Non-Hodgkin_lymphoma","Chemotherapy","CHOP","Diffuse_large_B-cell_lymphoma","European_Commission","Follicular_lymphoma","Biogen_Idec","Genentech","Hoffmann–La_Roche","European_Union","Chugai_Pharmaceuticals","B_cells","Hematological_malignancy","Leukemia","Lymphoma","Multiple_myeloma","Rheumatoid_arthritis","Methotrexate","TNF-alpha","Pharmacovigilance","Off-label","Multiple_sclerosis","Systemic_lupus_erythematosus","Anemia","Progressive_multifocal_leukoencephalopathy","Autoimmune_hemolytic_anemia","Pure_red_cell_aplasia","Idiopathic_thrombocytopenic_purpura","Evans_syndrome","Wegener's_Granulomatosis","Pemphigus","Pemphigoid","Pemphigus","Diabetes_mellitus","Sjogren's_syndrome","Devic's_disease","Chronic_fatigue_syndrome","Kidney_transplant","Cluster_of_differentiation","CD20","Plasma_cell","Calcium","Fragment_crystallizable_region","Antibody-dependent_cellular_cytotoxicity","Complement_system","Cell_cycle","MHC_II","CD23","B_cell_receptor","Apoptosis","Stem_cell","Amino_acid","Disulfide_bond","Death","Disability","Infusion_reaction","Cardiac_arrest","Cytokine_release_syndrome","Tumor_lysis_syndrome","Acute_renal_failure","Hepatitis_B","Progressive_multifocal_leukoencephalopathy","Lymphoma","Human_lung","Systemic_lupus_erythematosus","Progressive_multifocal_leukoencephalopathy","JC_virus","Rheumatoid_arthritis","Hepatitis_E","Acute_(medicine)","Ocrelizumab","Ofatumumab","Antibody-dependent_cellular_cytotoxicity","Antibody_variable_region","Belimumab","Atacicept","Food_and_Drug_Administration"]}